SPACInsider•20 hours ago
Pyxis Oncology, Inc. is a preclinical stage biopharmaceutical company developing cancers therapies. Its product candidate, PYX-106, targets thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors. PYX-102 is an investigational immune-therapeutic for treatment of solid tumors. Pyxis Oncology was incorporated in 2018 and is headquartered in Cambridge, MA.
What is Pyxis Oncology's quote symbol?
What is the 52 week high and low for Pyxis Oncology (NASDAQ: PYXS)?
How much is Pyxis Oncology stock worth today?
How much is Pyxis Oncology's stock price per share?
What is Pyxis Oncology's Market Cap?